The largest database of trusted experimental protocols

42 protocols using brij 58

1

Fatty Acid Utilization in Pseudomonas aeruginosa

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial strains and plasmids utilized in this study are listed in Table 1 and 2. E. coli EP-Max10B was used as cloning strains and cultured in Luria-Bertani (LB) medium (Difco). Pseudomonas Isolation Agar or Broth (PIA or PIB; Difco) or LB medium were used to culture P. aeruginosa strain PAO1 and derivatives. All fatty acids (FAs) stocks were made as previously described [17] (link). Strains for growth analyses were cultured in 1× M9 minimal medium +0.2% (w/v) Brij-58 (Sigma) +1% (w/v) casamino acids (CAA) or 0.4% (w/v) of the individual FA, C12∶0 to C16∶0, or C18∶1Δ9 (Sigma; Fig. 2) and 1× M9 minimal medium +0.2% (w/v) Brij-58 (Sigma) +0.4% (w/v) phosphatidylcholine (PC, Sigma; Fig. 3A), at 37°C with a shaking speed of 200 r.p.m. Since most of FAs hydrolyzed from in vivo PC are C16∶0 (50–60%), with ∼10–20% of each of C14∶0, C16∶1, C18∶1Δ9, and C18∶2 constituting the rest [43] (link), the growth analysis was performed in 1×M9 minimal medium supplied with each of C12∶0 (medium-chain fatty acid), C14∶0, C16∶0, and C18∶1Δ9 (LCFAs) as a sole carbon source. Accordingly, the PC we used in these in vitro experiments contains mostly LCFAs, approximately 33% C16∶0, 13% C18∶0, 31% C18∶1Δ9, and 15% C18∶2. The in vitro competition studies (Fig. 4A) were performed under the growth condition mentioned above as previously described [17] (link).
+ Open protocol
+ Expand
2

Topical Tacrolimus Formulation Development and Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TCR was purchased from CKD Bio Corporation (Ansan, Korea). Cocoglyceride was obtained from BASF (Ludwigshafen, Germany). The reference product was 0.1% Protopic® ointment (Astellas Pharm, Tokyo, Japan). Stearic acid was purchased from Tokyo Chemical Industry Co. Ltd (Tokyo, Japan). Poloxamer 188 was supplied by Croda International (Snaith, UK), and soybean lecithin was purchased from Samchun Chemical (Pyeongtaek, Korea). Brij® 93 and Brij® 58 were purchased from Sigma Aldrich Corporation (St. Louis, USA). Methylene chloride was purchased from OCI Corporation (Seoul, Korea). High-performance liquid chromatography (HPLC) grade ethanol and acetonitrile were purchased from Honeywell Burdick & Jackson (Muskegon, USA). Water was purified by filtration in the laboratory. HPLC-grade solvents were used for the analysis. Sprague Dawley® Rats and New Zealand white rabbits were purchased from Samtako Corporation (Osan, Korea).
+ Open protocol
+ Expand
3

Development of 5-FU Loaded Lipid Nanocarriers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lauric acid (LA), oleic acid (OA), linoleic acid (LIA), Brij 58, Span 80, ethanol and 5-FU were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). Dialysis bags (molecular weight cutoff value 8,000 Da) were purchased from Spectrum Labs (Rancho Dominguez, Canada). Tetrazolium dye (MTS) reagent for cell viability assay was purchased from Promega Corporation (Fitchburg, WI, USA). Human gingival fibroblast (HGF; PCS-201-108) cells and human breast adenocarcinoma cells (MDA-MB-231, HTB-26) were purchased from American Type Culture Collection (ATCC) (Manassas, VA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM) was purchased from GE Healthcare UK Ltd (Little Chalfont, UK). Milli Q deionized water (~18.2 μS) was used throughout the study.
+ Open protocol
+ Expand
4

Rabbit Muscle Fiber Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flash-frozen rabbit psoas muscles strips with a diameter of 1–2 mm were fully immersed in four 30-min changes of ice-cold fiber preparation buffer (6 mM imidazole, 8 mM Mg-acetate, 70 mM propionate, 5 mM EGTA, 7 mM ATP, and 1 mM Na-azide, pH 7.0). Skinning was then performed by soaking equilibrated samples for 2 h in a fiber preparation buffer with added 0.5% Brij 58 (P5884; Sigma-Aldrich). Skinned samples were stored in the fiber preparation buffer mixed 1:1 with ice-cold glycerol for 2 h before moving to −20°C for long-term storage.
Prior to myofibril preparation, the muscle strips were immersed in a wash buffer (6 mM Mg-acetate, 10 mM EGTA, 54 mM Na-acetate, 18 mM Na2SO4, 10 mM MOPS, 5 mM ATP, and 1 mM DTT, pH 7.4). The strips were separated into threads and transferred into a 2-ml tube containing 800 μl of wash buffer. Threads were twice homogenized using a Tissue Ruptor II with a rest period of 30 s (on ice). The myofibril concentration was kept constant by ensuring an OD600 of ∼0.8.
No live animals were used in these studies. Muscle tissue was collected in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and associated guidelines.
+ Open protocol
+ Expand
5

Glucuronidation of Fluorogenic Probe

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorogenic probe substrate N-butyl-4-(4-hydroxyphenyl)-1,8-naphthalimide (NHPN) and its O-glucuronide (NHPNG) were synthesized and purified (purity≥98%) according to the previously reported scheme [13 (link)]. Nilotinib and chrysin were from Dalian Meilun Biotech Co., Ltd. (Meilun, Dalian, China). The tissue preparations, including pooled human liver microsomes (HLM), pooled human intestine microsomes (HIM), pooled human kidney microsomes (HKM), and pooled human lung microsomes (HLuM) were purchased from Celsis Inc. (Baltimore, MD, USA). Recombinant human UGT1A1 was from BD Biosciences (Woburn, MA, USA). Stably transfected HeLa cells (named HeLa-UGT1A1 cells) were constructed as previously reported [[15] (link), [16] (link), [17] ]. The uridine diphosphate-glucuronic acid (UDPGA), polyethylene glycol hexadecyl ether (Brij 58) and anti-GAPDH antibody (G8795) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-UGT1A1 antibody (ab194697) was obtained from Abcam (Cambridge, MA). The reagents for the SimpleWestern blotting system were purchased from ProteinSimple (San Jose, CA). Ultrapure water purified by Milli-Q® Integral Water Purification System (Millipore, USA) was used throughout, while LC grade methanol, acetonitrile, and formic acid were ordered from Tedia (Fairfield, USA).
+ Open protocol
+ Expand
6

Synthesis of Porous Nanostructured Materials

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the chemicals used were of analytical grade. The surfactants (Pluronic P123; Brij-56, Brij-58 and CTAB), silica source (tetraethyl orthosilicate; TEOS), and carbon source (sucrose) were procured from Sigma-Aldrich. Other chemicals including, ethylenediamine (≥99.5%), carbon tetrachloride (≥99.5%) polyvinylpyrrolidone (PVP) (≥99.0), p-phenylenediamine (≥98.0%), anilines, and pyrrole, toluene, peroxy disulphate, HF (40% aqueous solution), HCl (36% aqueous solution), ammonia solution, were obtained from various chemical resources, viz., Sigma-Aldrich, and SD-fine chemicals.
+ Open protocol
+ Expand
7

Diacerein Loaded Lipid-based Formulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diacerein (DCN) was a kind gift from EVA Pharmaceutical Industries (Cairo, Egypt). Cholesterol (CH), Span 40 (sorbitan monopalmitate), Span 60 (sorbitan monostearate), Span 80 (sorbitan monooleate), Brij 58 (polyethylene glycol hexadecyl ether), Brij 72 (polyoxyethylene 2 stearyl ether), Brij S2 (polyoxyethylene (2) stearyl ether), Tween 20 (polyoxyethylene sorbitan monolaurate), Tween 80 (polyoxyethylene sorbitan monooleate), orthophosphoric acid and acetonitrile (HPLC grade) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Sodium taurocholate (STC) was acquired from BASF Co. (Florham Park, NJ, USA). Methanol, chloroform, disodium hydrogen phosphate, potassium dihydrogen phosphate and sodium chloride were purchased from El-Nasr Pharmaceutical Chemicals Co. (Abu-Zaabal, Cairo, Egypt).
+ Open protocol
+ Expand
8

Plasma Membrane Protein Extraction from Plant Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
The process of protein extraction and plasma membrane enrichment were modified from the previously published protocol (Collins et al., 2017 (link)). Briefly, fresh leaf tissues were ground using 1 mL ice-cold buffer H (250 mM sucrose, 50 mM HEPES-KOH pH 7.5, 5% glycerol, 50 mM NaPP, 1 mM NaMo, 25 mM NaF, 10 mM EDTA, 0.5% PVP, 3 mM DTT, 1 mM PMSF) per 0.2 g, and frozen root tissues were ground to a fine powder with 1 mL buffer H per 0.5 g fresh weight. The homogenate was then centrifuged for 10 min (10000 × g, 4°C),and the resulting supernatant was collected and centrifuged in an ultracentrifuge (Thermo Sorvall WX 100) for 30 min (100000 × g, 4°C) to pellet the crude microsomal fractions. The pellets were suspended and incubated in 2 μL of buffer H with 0.02% w/v Brij-58 (Sigma-Aldrich, America) per μg of microsomal protein on ice for 30 min, and then ultracentrifuged for 30 min (100000 × g, 4°C). The Brij-58 treatment and ultracentrifugation were repeated one more time to obtain the final enriched plasma membrane protein fraction.
+ Open protocol
+ Expand
9

Pseudovirus and Quasivirus Particle Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pseudovirus (PsV) and Quasivirus (QV) particles were produced by transfecting 293TT cells with HPV16 sheLL plasmids (a gift from the Schiller Lab, NCI, Bethesda, MD, USA) together with either the plasmid for secreted alkaline phosphatase (pSEAP) or cottontail rabbit papillomavirus (CRPV) genome respectively as previously described [23 (link),24 (link),45 (link),46 (link),47 (link)]. Two days post-transfection, cells were collected and lysed using the detergent Brij58 (Sigma-Aldrich, St. Louis, MO, USA). Particles were matured by incubating cell lysates at 37 °C for 24 h and subsequently treating with Benzonase (Sigma-Aldrich, St. Louis, MO, USA) and Plasmid Safe (Epicentre, Madison, WI, USA). Purification of the resulting particles was performed by ultracentrifugation of the lysates at 234,000× g for 3.5 h on an Optiprep step gradient (Sigma-Aldrich, St. Louis, MO, USA). Particles were harvested by puncturing the bottom of the centrifuge tube and collecting fractions of ~250 µL.
+ Open protocol
+ Expand
10

Whole-Genome Profiling of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suspensions were prepared from individual colonies after culture on Blood Columbia agar. OD at 600 nm was measured and suspensions were diluted to 109 CFU/ml in EDTA-saline buffer (75 mmol/L NaCl and 25 mmol/L EDTA, pH 7.5), then mixed with an equal volume of 1% low-melting-point agarose and allowed to solidify in a 100 μL plug mould. The agarose plug was incubated for 24 h at 37°C in 500 μL lysis buffer (6 mmol/L Tris–HCl (pH 7.6), 0.1 mol/L EDTA, 1 mol/L NaCl, 0.5% Brij®58 (polyoxyethylene (20) cetyl ether; Sigma), 0.4% sodium deoxycholate, 0.5% sodium lauryl sarcosine and 1 mg/mL lysozyme (and 10 µg/mL lysostaphin to S. aureus)). The lysis buffer was replaced with 500 μL proteinase K buffer (1% sodium lauryl sarcosine, 0.5 mol/L EDTA (pH 9) and proteinase K (50 μg/mL; Sigma)) and this solution was incubated with gentle shaking at 50°C for 20 h. The plugs were then washed four times for 30 min at 37°C with 10 mL of Tris–EDTA buffer (10 mmol/L Tris–HCl (pH 8) and 1 mmol/L EDTA). One-third of a slice of each plug was cut and incubated for 18–20 h with 30 U of SpeI, or SmaI, XbaI and Cfr9I in the restriction buffer (Thermo scientific). DNA restriction fragments were separated in a PFGE apparatus at 14°C, 6 V/cm, for a specific time for each species (19–23 h). The gel was stained with gel-red and visualized with a UV system.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!